Why Traditional EMRs Are Holding Healthcare Back
Instead of creating new opportunities, traditional EMRs are constraining AI’s potential in healthcare. The post Why Traditional EMRs Are Holding Healthcare Back appeared first on MedCity News.
Read More
It Took Years for Congress to Enact PBM Transparency, Delinking. What About Vertical Integration?
Experts say the bipartisan Break Up Big Medicine Act — aimed at breaking up vertically integrated healthcare companies — faces slim chances of passing despite recent PBM reforms. The post It Took Years for Congress to Enact PBM Transparency, Delinking. What About Vertical Integration? appeared first on MedCity News.
It Doesn’t All Have to Be Doom and Gloom for Rural Hospitals – A Blueprint for Improving Cost Structures
We now have technology that can address the problems faced by so many rural hospitals, improving both patient outcomes and an organization’s bottom line. The post It Doesn’t All Have to Be Doom and Gloom for Rural Hospitals – A Blueprint for Improving Cost Structures appeared first on MedCity News.
Why HHS’ Notice On Federal Public Benefits Harms Both Lawfully Present and Undocumented Immigrants
Numerous advocacy organizations are sounding the alarm over a recent HHS notice that restricts access to federal benefits for undocumented immigrants, as well as for those lawfully present. The post Why HHS’ Notice On Federal Public Benefits Harms Both Lawfully Present and Undocumented Immigrants appeared first on MedCity News.
3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders
Bicara Therapeutics’ IPO raised $315 million raised for Phase 3 testing of a bifunctional antibody drug with potential to become a first-line treatment for head and neck cancers. Zenas BioPharma and MBX Biosciences also went public; all three companies upsized their IPOs. The post 3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology…
Medicaid: nuevo requisito federal de trabajo deja a estados sin mucho margen de maniobra
Cuando el presidente Donald Trump firmó una ley que agrega requisitos laborales para algunos beneficiarios de Medicaid, es posible que haya perjudicado a legisladores de al menos 14 estados que estaban diseñando sus propios planes, según observadores del sector de salud. Georgia es el único estado con un requisito laboral para Medicaid, pero varios estados…
Can House Republicans Cut $880 Billion Without Slashing Medicaid? It’s Likely Impossible.
The prospect of deep Medicaid cuts has become a flashpoint in Congress, with leaders of both parties accusing their counterparts of lying. House Democratic leader Hakeem Jeffries said Feb. 27 that a Republican budget measure would “set in motion the largest cut to Medicaid in American history,” and that Republicans are hiding the consequences. “The…
J&J’s Imaavy Becomes First FDA-Approved Therapy for Rare Form of Anemia
Johnson & Johnson antibody drug Imaavy expanded its label to include the treatment of warm autoimmune hemolytic anemia (wAIHA). Projected to become a blockbuster seller across multiple indications, Imaavy was first approved last year for treating generalized myasthenia gravis. The post J&J’s Imaavy Becomes First FDA-Approved Therapy for Rare Form of Anemia appeared first on…
Digital Health Funding in H1 2025: Market Stabilizes, AI Dominates and Exits Return
Digital health funding held steady in the first half of 2025, with AI-focused startups capturing the majority of capital and driving rapid adoption among providers. The digital health space also saw two long-awaited IPOs as well as rising M&A activity, which are two signals of market maturity — but looming policy shifts may challenge long-term…
Atherosclerosis and Osteoporosis: A Tale of Two Conditions
Why has there been so little progress against the rate of osteoporotic fractures and the associated morbidity and mortality? The deaths are real, the pain and suffering are real — and almost all of us have witnessed it. And, of course, the cost to our health system, $57 billion per year, is real. The post…